Zhang Q - Search Results

1

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.

Yuan G, Song Y, Li Q, Hu X, Zang M, Dai W, Cheng X, Huang W, Yu W, Chen M, Guo Y, Zhang Q, Chen J. Yuan G, et al. Among authors: zhang q. Front Immunol. 2021 Jan 8;11:613946. doi: 10.3389/fimmu.2020.613946. eCollection 2020. Front Immunol. 2021. PMID: 33488622 Free PMC article.

2

A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.

Peng J, Zhang J, Zhang Q, Xu Y, Zhou J, Liu L. Peng J, et al. Among authors: zhang q, zhang j. Diagn Interv Radiol. 2018 May-Jun;24(3):121-127. doi: 10.5152/dir.2018.17467. Diagn Interv Radiol. 2018. PMID: 29770763 Free PMC article.

3

Next-Generation Sequencing Characterizes the Landscape of Somatic Mutations and Pathways in Metastatic Bile Tract Carcinoma.

Li Q, Zhang Q, Cheng X, Weng X, Chen M, Hu X, Huang J, Chen J. Li Q, et al. Among authors: zhang q. J Oncol. 2020 Sep 4;2020:3275315. doi: 10.1155/2020/3275315. eCollection 2020. J Oncol. 2020. PMID: 32952556 Free PMC article.

4

A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients.

Liao M, Sun J, Zhang Q, Tang C, Zhou Y, Cao M, Chen T, Hu C, Yu J, Song Y, Li M, Liao W, Zhou Y. Liao M, et al. Among authors: zhang q. Front Oncol. 2021 Jul 6;11:665497. doi: 10.3389/fonc.2021.665497. eCollection 2021. Front Oncol. 2021. PMID: 34295811 Free PMC article.

5

Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing.

Li Q, Zhang Q, Chen J, Zang M, Hu X, Li R, Hou J, Zhou J. Li Q, et al. Among authors: zhang q. J Gastrointest Oncol. 2022 Aug;13(4):1864-1874. doi: 10.21037/jgo-22-556. J Gastrointest Oncol. 2022. PMID: 36092348 Free PMC article.

6

Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.

Zhang Q, Sun S, Zhu C, Zheng Y, Cai Q, Liang X, Xie H, Zhou J. Zhang Q, et al. Mol Med Rep. 2019 Apr;19(4):2479-2488. doi: 10.3892/mmr.2019.9929. Epub 2019 Feb 4. Mol Med Rep. 2019. PMID: 30720105 Free PMC article.

7

Expression of Allograft Inflammatory Factor-1 (AIF-1) in Hepatocellular Carcinoma.

Zhang Q, Sun S, Zhu C, Xie F, Cai Q, Sun H, Chen G, Liang X, Xie H, Shi J, Liao Y, Zhou J. Zhang Q, et al. Med Sci Monit. 2018 Sep 6;24:6218-6228. doi: 10.12659/MSM.908510. Med Sci Monit. 2018. PMID: 30188879 Free PMC article.

8

Integrative epigenetic analysis reveals AP-1 promotes activation of tumor-infiltrating regulatory T cells in HCC.

Zhuo B, Zhang Q, Xie T, Wang Y, Chen Z, Zuo D, Guo B. Zhuo B, et al. Among authors: zhang q. Cell Mol Life Sci. 2023 Mar 20;80(4):103. doi: 10.1007/s00018-023-04746-3. Cell Mol Life Sci. 2023. PMID: 36941472 Free PMC article.

9

ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway.

Zhang Q, Zhang Y, Sun S, Wang K, Qian J, Cui Z, Tao T, Zhou J. Zhang Q, et al. Among authors: zhang y. Cell Death Dis. 2021 Jan 4;12(1):15. doi: 10.1038/s41419-020-03291-2. Cell Death Dis. 2021. PMID: 33414412 Free PMC article.

10

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma.

Zhang Q, Xiao Z, Sun S, Wang K, Qian J, Cui Z, Tao T, Zhou J. Zhang Q, et al. Cancer Manag Res. 2021 Mar 11;13:2307-2317. doi: 10.2147/CMAR.S291811. eCollection 2021. Cancer Manag Res. 2021. PMID: 33732023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70,011 results

Search Page

Filters